2024 Q2 Form 10-Q Financial Statement

#000107997324000567 Filed on April 22, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $333.6K $356.1K $305.1K
YoY Change -43.0% 16.71% -35.38%
Cost Of Revenue $155.8K $160.7K $139.6K
YoY Change -42.0% 15.16% -33.5%
Gross Profit $177.8K $195.3K $165.5K
YoY Change -43.85% 18.01% -36.88%
Gross Profit Margin 53.29% 54.86% 54.26%
Selling, General & Admin $219.1K $257.4K $233.0K
YoY Change -6.7% 10.49% 4.98%
% of Gross Profit 123.27% 131.79% 140.76%
Research & Development $35.08K $28.95K $28.66K
YoY Change 25.2% 0.99% -37.39%
% of Gross Profit 19.73% 14.82% 17.32%
Depreciation & Amortization $1.970K $93.00 $40.00
YoY Change 418.42% 132.5% -63.64%
% of Gross Profit 1.11% 0.05% 0.02%
Operating Expenses $254.2K $286.4K $261.7K
YoY Change -3.3% 9.45% -2.27%
Operating Profit -$76.45K -$91.04K -$96.13K
YoY Change -242.4% -5.29% 1660.55%
Interest Expense $5.590K $5.470K $4.000K
YoY Change 7.92% 36.75% 716.33%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$70.86K -$85.57K -$92.12K
YoY Change -220.37% -7.11% 1757.34%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$70.86K -$85.57K -$92.12K
YoY Change -220.37% -7.11% 1757.34%
Net Earnings / Revenue -21.24% -24.03% -30.2%
Basic Earnings Per Share -$0.01 -$0.02 -$0.02
Diluted Earnings Per Share -$0.01 -$0.02 -$0.02
COMMON SHARES
Basic Shares Outstanding 4.947M shares 4.947M shares 4.947M shares
Diluted Shares Outstanding 4.947M shares 4.947M shares 4.947M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $722.6K $835.2K $844.1K
YoY Change -7.6% -1.06% -23.31%
Cash & Equivalents $322.6K $435.2K $592.4K
Short-Term Investments $400.0K $400.0K $251.7K
Other Short-Term Assets $20.96K $17.35K $99.90K
YoY Change -74.66% -82.63% 144.25%
Inventory $748.3K $629.6K $729.3K
Prepaid Expenses $20.96K $17.35K $36.90K
Receivables $76.32K $111.9K $107.8K
Other Receivables $1.240K $1.330K $680.00
Total Short-Term Assets $1.569M $1.595M $1.782M
YoY Change -16.69% -10.46% 3.71%
LONG-TERM ASSETS
Property, Plant & Equipment $17.50K $17.25K $9.876K
YoY Change -75.25% 74.66% -52.13%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $27.87K $37.87K $69.86K
YoY Change -60.6% -45.79% 238.8%
TOTAL ASSETS
Total Short-Term Assets $1.569M $1.595M $1.782M
Total Long-Term Assets $27.87K $37.87K $69.86K
Total Assets $1.597M $1.633M $1.852M
YoY Change -18.28% -11.8% 6.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $74.12K $30.78K $64.08K
YoY Change -20.98% -51.97% 28.94%
Accrued Expenses $52.42K $60.75K $72.12K
YoY Change -45.42% -15.77% 35.84%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $126.5K $91.52K $136.2K
YoY Change -33.35% -32.81% 32.5%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $20.20K
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $20.20K
YoY Change -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $126.5K $91.52K $136.2K
Total Long-Term Liabilities $0.00 $0.00 $20.20K
Total Liabilities $126.5K $91.52K $156.4K
YoY Change -36.7% -41.49% 52.15%
SHAREHOLDERS EQUITY
Retained Earnings $532.8K $603.6K $757.9K
YoY Change -34.77% -20.35%
Common Stock $4.947K $4.947K $4.947K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.471M $1.542M $1.695M
YoY Change
Total Liabilities & Shareholders Equity $1.597M $1.633M $1.852M
YoY Change -18.28% -11.8% 6.5%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$70.86K -$85.57K -$92.12K
YoY Change -220.37% -7.11% 1757.34%
Depreciation, Depletion And Amortization $1.970K $93.00 $40.00
YoY Change 418.42% 132.5% -63.64%
Cash From Operating Activities -$111.2K -$51.07K -$149.7K
YoY Change 117.05% -65.88% -393.42%
INVESTING ACTIVITIES
Capital Expenditures $1.300K $9.000K
YoY Change -87.93%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities -$1.300K -$9.000K
YoY Change -99.18% -106.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -111.2K -$51.07K -$149.7K
Cash From Investing Activities -1.300K -$9.000K
Cash From Financing Activities
Net Change In Cash -112.5K -$51.07K -$158.7K
YoY Change -46.49% -67.82% -181.36%
FREE CASH FLOW
Cash From Operating Activities -$111.2K -$51.07K -$149.7K
Capital Expenditures $1.300K $9.000K
Free Cash Flow -$112.5K -$51.07K -$158.7K
YoY Change 81.46% -67.82% -411.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4946502 shares
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
435181 usd
CY2024Q1 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
400000 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
111866 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
629606 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
17354 usd
CY2024Q1 us-gaap Interest Receivable Current
InterestReceivableCurrent
1331 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
1595338 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17249 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
20620 usd
CY2024Q1 us-gaap Assets
Assets
1633207 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
30778 usd
CY2024Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
5655 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
20937 usd
CY2024Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
27004 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7149 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
91523 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4946502 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4946502 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
4947 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
933105 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
603632 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1541684 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1633207 usd
CY2024Q1 us-gaap Revenues
Revenues
356061 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
160715 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
139560 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
195346 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
165529 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
88778 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
84765 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28947 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28663 usd
CY2024Q1 us-gaap Marketing Expense
MarketingExpense
168665 usd
CY2023Q1 us-gaap Marketing Expense
MarketingExpense
148227 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
286390 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
261655 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-91044 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-96126 usd
CY2024Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
5470 usd
CY2023Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
4002 usd
CY2024Q1 us-gaap Other Income
OtherIncome
5470 usd
CY2023Q1 us-gaap Other Income
OtherIncome
4002 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-85574 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-92124 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-85574 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-92124 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4946502 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4946502 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4946502 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4946502 shares
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-85574 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-92124 usd
CY2024Q1 us-gaap Depreciation
Depreciation
93 usd
CY2023Q1 us-gaap Depreciation
Depreciation
38 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
913 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
59274 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-33624 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-92851 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3830 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-575 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-126 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1924 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-5731 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-6577 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-74912 usd
CY2024Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
3998 usd
CY2023Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-18354 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-51071 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-149701 usd
CY2024Q1 us-gaap Proceeds From Payments For In Interest Bearing Deposits In Banks
ProceedsFromPaymentsForInInterestBearingDepositsInBanks
300000 usd
CY2023Q1 us-gaap Proceeds From Payments For In Interest Bearing Deposits In Banks
ProceedsFromPaymentsForInInterestBearingDepositsInBanks
300000 usd
CY2024Q1 us-gaap Payments For Proceeds From Other Interest Earning Assets
PaymentsForProceedsFromOtherInterestEarningAssets
300000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Interest Earning Assets
PaymentsForProceedsFromOtherInterestEarningAssets
300000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-51071 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-158701 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
486252 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
751118 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
435181 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
592417 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1787348 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-92124 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1695224 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1627258 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-85574 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1541684 usd
CY2024Q1 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
108085 usd
CY2023Q4 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
118472 usd
CY2024Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
227871 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
313597 usd
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
293650 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
290388 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
629606 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
722457 usd
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
225000 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
180000 shares
CY2024Q1 ELST Sales Order Backlog
SalesOrderBacklog
10346 usd
CY2023Q1 ELST Sales Order Backlog
SalesOrderBacklog
162396 usd
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001079973-24-000567-index-headers.html Edgar Link pending
0001079973-24-000567-index.html Edgar Link pending
0001079973-24-000567.txt Edgar Link pending
0001079973-24-000567-xbrl.zip Edgar Link pending
elst-20240331.xsd Edgar Link pending
elst_10q-033124.htm Edgar Link pending
ex31x1.htm Edgar Link pending
ex31x2.htm Edgar Link pending
ex32x1.htm Edgar Link pending
ex32x2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
elst-20240331_cal.xml Edgar Link unprocessable
elst-20240331_def.xml Edgar Link unprocessable
elst-20240331_lab.xml Edgar Link unprocessable
elst-20240331_pre.xml Edgar Link unprocessable
elst_10q-033124_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending